Oscar Health Beats Expectations With Record Profits and Raises 2026 Outlook
Membership near 3M as medical costs ease and outlook rises.
Already have an account? Sign in.
Membership near 3M as medical costs ease and outlook rises.
Xos secures its first U.S. Air Force contract to build a military-grade Xos Hub mobile charging system, marking its entry into defense.
Topline data from Amylyx’s Phase 3 LUCIDITY trial of avexitide for PBH arrives August 18. Prior results and unmet need fuel optimism.
4D Molecular gains support as B. Riley views EyePoint’s Phase 3 setback as favorable for its lead gene therapy candidate 4D-150.